Kaufman, Cary S.
Article History
Received: 26 October 2020
Accepted: 27 October 2020
First Online: 17 November 2020
Disclosure
: Cary S. Kaufman was the primary investigator receiving research support from Focal Therapeutics, Inc. for the registry trial described in this editorial. Focal Therapeutics has since been purchased by Hologic Inc., with which Dr. Kaufman has no financial relationship with regard to this research.